Objectives: The main objective of this study was to investigate the effects of pneumococcal hyaluronidase (0.1-10 mg/ml), alone and in combination with pneumolysin (50 and 100 ng/ml), on human ciliated epithelium. Methods: Ciliary beat frequency (CBF) and structural integrity of human ciliated respiratory epithelium in vitro were studied using a phototransistor technique and a visual scoring index, respectively. Results: Hyaluronidase per se did not affect either CBF or the structural integrity of the epithelium. However, preincubation of the epithelial strips with hyaluronidase (10 mg/ml) for 30 min at 37 8C significantly potentiated pneumolysin-mediated ciliary slowing and epithelial damage. Hyaluronan, a substrate of hyaluronidase, had no effects on the ciliated respiratory epithelium in concentrations up to 100 mg/ml and did not antagonize the injurious effects of pneumolysin on the epithelium. However, preincubation of the epithelial strips with hyaluronan (100 mg/ml) was associated with attenuation of the ciliary slowing and epithelial damage induced by incubation of the strips with hyaluronidase (10 mg/ml) for 30 min at 37 8C followed by addition of pneumolysin (50 ng/ml). Conclusions: Although having no direct effects alone, hyaluronidase may contribute to pneumolysin-mediated damage and dysfunction to respiratory epithelium, thereby favoring colonization and subsequently extra-pulmonary dissemination of the pneumococcus. #
Introduction
Pneumococcal hyaluronidase is a hyaluronate lyase that degrades primarily hyaluronan (hyaluronic acid) by cleaving its hexosaminidic linkages, 1 but may also cleave other polysaccharide components of intercellular ground substance such as chondroitin or chondroitin sulfates. 1 The enzyme uses a b-elimination mechanism to degrade its substrate(s) as opposed to other hyaluronidases that often utilize hydrolysis. 2 The vast majority of pneumococcal clinical isolates produce hyaluronidase, and it has been suggested that the enzyme may be an important virulence factor of the pneumococcus, playing a role both in colonization and invasion. 3 Evidence for the role of hyaluronidase in the pathogenesis of pneumococcal infections is based on a number of experimental studies. 1, 4 For example, in a mouse model of meningitis, using pneumococcal clinical isolates derived from children with purulent meningitis, one of the most important factors associated with the development of experimental meningitis was high hyaluronidase activity, 4 suggesting that hyaluronidase may play a role in bacterial dissemination and invasion, and in breaching the blood-brain barrier. 1, 4 Other investigators have confirmed that hyaluronidase is involved in the pathogenesis of meningitis in a murine model of experimental infection and have suggested that this enzyme facilitates bloodstream invasion after colonization of the upper respiratory tract by ''loosening the barrier function of the nasopharyngeal mucosa''. 1 It appears that hyaluronidase may facilitate translocation of organisms from the lung to the vascular system, while others have noted the importance of hyaluronidase production among pneumococcal isolates causing otitis media. 5 To our knowledge, no previous studies have addressed the effects of hyaluronidase on human ciliated epithelium, although several have documented that pneumolysin, the thiol-activated protein of the pneumococcus, does cause slowing of ciliary beating and damage to the epithelium. 6 In the current study we have investigated the effects of hyaluronidase on human ciliated epithelium in vitro, as well as the effects of prior incubation of epithelium with this enzyme on pneumolysin-mediated epithelial injury (ciliary slowing and epithelial damage).
Materials and methods

Toxins, chemicals and reagents
Recombinant pneumolysin and hyaluronidase were expressed in Escherichia coli and purified from cell extracts as previously described. 7, 8 Unless otherwise indicated all other chemicals and reagents were purchased from the Sigma Chemical Co., St Louis, MO, USA, while indicator-free Hank's balanced salt solution (HBSS) was purchased from Highveld Biological (Pty) Ltd, Johannesburg, South Africa.
Human nasal epithelium
This study was approved unconditionally by the Human Research Ethics Committee of the University of the Witwatersrand, Johannesburg, South Africa.
Strips of human nasal ciliated epithelium were obtained by brushing the inferior nasal turbinate of healthy human volunteers using a 2-mm bronchoscopy cytology brush, and a single donor was used for each set of experiments, as previously described. 6, 9 The strips of epithelium were collected into HBSS, and the specimen was then divided into the appropriate number of 2-ml aliquots, and each aliquot was centrifuged at 150 Â g for 10 min. Thereafter, the supernatant of each aliquot was aspirated and replaced by 800 ml of either HBSS alone (control preparation) or HBSS containing differing combinations of the various test substances (test preparation). A closed microscope coverslipslide preparation was then prepared for each of the specimens, as previously described. 6, 9 For each experimental system it was ensured that the pH of the preparations was at, or close to, 7.4 both at the beginning and at the end of the experiment.
After coding by an independent observer, the preparations were inspected in a blinded fashion, initially, and then hourly for 4 h, using a Leitz orthoplan phase contrast microscope (Leitz, Germany) fitted with an electronically controlled warmstage set to 37 8C (Sensicon, LHE Laboratories, UK). Ciliary beat frequency (CBF) was measured using a phototransistor technique, as previously described. 10 A total of ten readings of CBF were obtained from each preparation, from the same areas, at each time point. The mean CBF was measured as the mean value of the ten readings at each time point. Percent ciliary slowing (CS) was calculated by subtracting the lowest mean test CBF (invariably at the end of 4 hours) from the mean control CBF at the same time point, divided by the mean control CBF Â 100. In addition, at each of these sites at which CBF was measured, the presence or absence of epithelial injury or damage (ED) was recorded, using a visual scoring index, previously described. 9 In short, the presence of disruption of the normal integrity of the epithelial surface (presence of irregular contour and breakup of the normally smooth outline) was recorded by the same investigator as being either absent or present at the same sites at which the recordings of the CBF were undertaken.
Experimental systems were designed to investigate the following:
1. The effects of hyaluronidase alone (0.1-10 mg/ml) on the CBF and structural integrity of human ciliated epithelium by measuring percent ciliary slowing (% CS) and percent epithelial damage (% ED). 2. The effects of preincubation of the epithelial strips with hyaluronidase (final concentration 10 mg/ml) for 30 min at 37 8C on the % CS and % ED induced by pneumolysin (50 ng/ml and 100 ng/ml). 3. The effects of preincubation of the epithelial strips with hyaluronan (final concentration 100 mg/ml) for 30 min at 37 8C on the % CS and % ED induced by pneumolysin (50 ng/ml) in the presence and absence of hyaluronidase (10 mg/ml).
The concentrations of pneumolysin used in the current experiments were based on our previous experience with the effects of this toxin on human ciliated epithelium 9 and are well within the concentrations of pneumolysin that have been measured in the cerebrospinal fluid (CSF) of patients with pneumococcal meningitis. 11 The concentrations of hya-luronidase and hyaluronan used in the current study were comparable to those used in previous studies. 12, 13 Those of hyaluronidase were also based on the following calculations: we estimated that in the study by Berry and colleagues, 14 approximately 11.2 mg of hyaluronidase were produced per ml of culture and, notwithstanding differences in the various assays, we calculated that the amounts of hyaluronidase produced in relationship to pneumolysin were in a ratio of approximately 100 to 1, which is close to that used in the current study. In the case of hyaluronan, the concentration used was the highest concentration that did not appear to interfere mechanically with the ciliary beating in association with its high viscosity.
Neutrophils and erythrocytes
These cells were used to investigate the effects of hyaluronidase (10 mg/ml) in the presence and absence of pneumolysin on the structural integrity of single cells in suspension, as opposed to solid tissue (epithelial strips). Influx of extracellular Ca 2+ and release of hemoglobin were used to investigate the effects of the two pneumococcal proteins on the structural integrity of human neutrophils and erythrocytes, respectively. Neutrophils were isolated from the blood of healthy adult human volunteers as previously described, 15 and resuspended to a concentration of 1 Â 10 7 /ml in phosphate-buffered saline (0.15 M; pH 7.4), while washed erythrocytes (5%) were suspended in HBSS.
To measure influx of Ca 2+ into neutrophils, the cells (1 Â 10 7 /ml) were treated with the calcium-sensitive fluorescent dye, fura-2/AM for 30 min at 37 8C, followed by washing. The fura-2-loaded cells were then resuspended in HBSS and preincubated for 10 min at 37 8C (2 Â 10 6 cells/ml) followed by transfer to thermoregulated cuvettes in a Hitachi 650 10S fluorescence spectrophotometer with excitation and emission wavelengths set at 340 and 500 nm respectively, and addition 1 min later of either hyaluronidase (10 mg/ml, final) or pneumolysin at a predetermined concentration of 8.37 ng/ ml. This is a sub-cytolytic concentration of pneumolysin for neutrophils, which promotes influx of extracellular Ca 2+ . 15 When the pneumococcal proteins were used in combination, the cells were pretreated with hyaluronidase for 10 min at 37 8C, followed by addition of pneumolysin. In the hemolysis system, hyaluronidase (10 mg/ml) or pneumolysin (4.8 and 8.37 ng/ml) were added to erythrocytes (0.5%, final), which had been preincubated for 10 min at 37 8C. The cells were then incubated for 30 min at 37 8C after which intact cells and cell debris were pelleted by centrifugation and hemoglobin in the supernatants assayed spectrophotometrically at 405 nm. In combination experiments, the cells were pretreated with hyaluronidase for 10 min at 37 8C followed by addition of pneumolysin.
These systems (influx of Ca 2+ into neutrophils and hemolysis) were also used to investigate the effects of hyaluronan (100 mg/ml) on the pore-forming actions of pneumolysin.
Statistical analysis
Each of the series of experiments on the ciliated epithelium was repeated a minimum of six times, unless otherwise indicated. All data were recorded as the mean and standard deviation (SD). The ciliary beat frequency, % CS and % ED were compared in control and test preparations using the Mann-Whitney U-test (two-tailed). A p value of <0.05 was considered to be significant.
Results
Effects of hyaluronidase alone on human ciliated epithelium (n = 2)
At concentrations between 0.1 and 10 mg/ml, hyaluronidase alone had no effect on human ciliated epithelium over 4 h in vitro. There was no change in ciliary beat frequency nor any evidence of epithelial disruption (ED) (mean CBF of control epithelial strips 11.7 AE 0.82 Hz, no ED; mean CBF of strips exposed to 0.1 mg/ml of hyaluronidase 11.6 AE 0.70 Hz, no ED; mean CBF of strips exposed to 1 mg/ml of hyaluronidase 11.1 AE 0.74 Hz, no ED; mean CBF of strips exposed to 10 mg/ml of hyaluronidase 11.5 AE 0.71 Hz, no ED). Table 1 The effects of incubation with hyaluronidase followed by pneumolysin on human ciliated epithelium in vitro, measuring ciliary beat frequency (CBF) and percent epithelial damage (% ED)
Experimental system CBF (Hz) % ED Significance
Epithelial strips in HBSS (control) 11.2 AE 0.24 0% -Epithelial strips exposed to pneumolysin (50 ng/ml) 9.9 AE 0.78 22% <0.005 a Epithelial strips exposed to hyaluronidase (10 mg/ml) followed by pneumolysin (50 ng/ml) 8.5 AE 0.69 32% <0.005 a <0.005 b Epithelial strips exposed to pneumolysin (100 ng/ml) 8.5 AE 0.44 28% <0.005 a Epithelial strips exposed to hyaluronidase (10 mg/ml) followed by pneumolysin (100 ng/ml) 7.5 AE 1.01 42% <0.005 a NS c a CBF compared to control and % ED compared to control. The p values remained significant when a Bonferroni correction for multiple comparisons was applied.
b CBF compared to equivalent experimental system without hyaluronidase. The p values remained significant when a Bonferroni correction for multiple comparisons was applied. The % ED was not significantly different when compared to the experimental system without hyaluronidase. c NS not significant for both CBF and % ED compared to the equivalent experimental system without hyaluronidase.
Effects of prior incubation of the epithelial strips with hyaluronidase on the ciliary beat frequency and epithelial damage induced by pneumolysin (n = 6)
Pneumolysin per se at both concentrations used (50 and 100 ng/ml) caused dose-dependent ciliary slowing and damage to the structural integrity of the epithelial strips (Table 1) . These effects were significantly enhanced by prior exposure of the epithelial strips to hyaluronidase (10 mg/ml).
Effects of hyaluronan on the ciliary beat frequency and epithelial damage mediated by hyaluronidase in combination with pneumolysin (n = 6)
Preliminary experiments demonstrated that hyaluronan per se at concentrations of up to 100 mg/ml, and over the time course of our experiments, had no effect on human ciliated epithelium (data not shown). As shown in Table 2 , prior incubation of the epithelial strips with hyaluronan partially attenuated the ciliary slowing and epithelial damage induced by incubation of the strips with hyaluronidase (10 mg/ml) for 30 min at 37 8C followed by addition of pneumolysin (50 ng/ ml). Importantly, hyaluronan did not antagonize the injurious effects of pneumolysin per se on the ciliated epithelium (not shown).
Neutrophils and erythrocytes
Hyaluronidase (10 mg/ml) did not cause influx of Ca 2+ into neutrophils or hemolysis, while pretreatment of neutrophils and erythrocytes with this enzyme or with hyaluronan did not alter the sensitivities of these cells to the pore-forming actions of pneumolysin (not shown).
Discussion
Pneumococcal hyaluronidase has been reported to enhance the virulence of the pneumococcus by subverting the structural integrity of epithelial barriers, thereby favoring colonization and dissemination of this microbial pathogen. 1, 5 In the current study, we have identified an additional mechan-ism by which hyaluronidase, acting in concert with pneumolysin, compromises epithelial function and structural integrity. Pneumolysin, which possesses both cytotoxic and proinflammatory properties, 15, 16 has well-recognized detrimental effects on the structure and function of ciliated epithelium. 6, 9 All of these actions of the toxin, which are secondary to its pore-forming activities, 16 are thought to contribute to the virulence of the pneumococcus. Our current observations demonstrate that while hyaluronidase per se has no detectable effects on respiratory epithelium, prior treatment of the ciliated epithelial strips with this enzyme resulted in increased ciliary dysfunction and epithelial damage on subsequent exposure to pneumolysin. Inclusion of hyaluronan, which did not affect the pore-forming actions of pneumolysin, partially negated hyaluronidase-mediated sensitization of the epithelium to the injurious actions of pneumolysin, implying primary involvement of the enzymatic activity of hyaluronidase.
These observations are compatible with a mechanism whereby hyaluronidase, by enzymatically dismantling the intercellular matrix and/or hydrolysis of hyaluronan in epithelial lining fluid, 12, 13 or by some other means, increases the accessibility of epithelial cells to pneumolysin. In possible support of this suggestion is a previous study which documents the ability of hyaluronidase to shift mucus off epithelia, which represents another mechanism that may increase access of pneumolysin to the epithelium. 17 This contention is also reinforced by the failure of hyaluronidase to increase the sensitivity of single-cell suspensions (erythrocytes and neutrophils) to pneumolysin.
Interestingly, interactions between hyaluronidase and pneumolysin as described in the current study, may be a strategy utilized by the pneumococcus to maximize virulence, as has recently been proposed by Berry and Paton. 18 These authors used a series of mutants of the pneumococcus in which one or more of the genes encoding selected protein virulence factors had been disabled. Using a murine model of experimental peritonitis, they observed that inactivation of pneumolysin production, but not that of hyaluronidase, resulted in attenuation of pneumococcal virulence, which was, however, most pronounced following dual knockout of the genes encoding each of these proteins. 18 In conclusion, the current study has identified novel mechanisms involving interactions between hyaluronidase 14
C. Feldman et al. Table 2 The effects of preincubation of epithelial strips with hyaluronan on the ciliary beat frequency (CBF) and percent epithelial damage (% ED) induced by exposure to hyaluronidase and pneumolysin
Experimental system CBF (Hz) % ED Significance
Epithelial strips in HBSS (control) 11.3 AE 0.26 0% -Epithelial strips exposed to pneumolysin (50 ng/ml) 10.1 AE 0.29 20% <0.005 a Epithelial strips exposed to hyaluronidase (10 mg/ml) followed by pneumolysin (50 ng/ml) 8.2 AE 0.42 40% <0.005 a Epithelial strips preincubated with hyaluronan (100 mg/ml) and then exposed to hyaluronidase (10 mg/ml) followed by pneumolysin (50 ng/ml) 9.1 AE 0.59 32% <0.005 a <0.05 b and pneumolysin, which may contribute to the pathogenesis of invasive pneumococcal disease. Such insights are necessary, not only to enable innovative vaccine design, but also to facilitate the development of adjunctive strategies to antibiotics in severe pneumococcal disease. Conflict of interest: No conflict of interest to declare.
